Similar results have been gained from a rapid autopsy study investigating the second-generation prostate-specific membrane antigen (PSMA) agent 18F-DCFPyL demonstrating an accurate detection of sites of metastatic ccRCC 60. Here, FOLH1 is linked to nonpapillary renal cell carcinoma.